The Usefulness of Microencapsulated Sodium Butyrate Add-On Therapy in Maintaining Remission in Patients with Ulcerative Colitis: A Prospective Observational Study

The Usefulness of Microencapsulated Sodium Butyrate Add-On Therapy in Maintaining Remission in Patients with Ulcerative Colitis: A Prospective Observational Study

Butyrate is a short-chain fatty acid that plays a key role in maintaining gut homeostasis as well as the integrity of the intestinal barrier. In the present study, we investigated the effect of oral microencapsulated sodium butyrate (BLM) administration in maintaining remission and improving residua...

Full description

Bibliographic Details
Main Authors:	Marta Vernero, Federico De Blasio, Davide Giuseppe Ribaldone, Elisabetta Bugianesi, Rinaldo Pellicano, Giorgio Maria Saracco, Marco Astegiano, Gian Paolo Caviglia
Format:	Article
Language:	English
Published:	MDPI AG 2020-12-01
Series:	Journal of Clinical Medicine
Subjects:	calprotectin complementary therapy IBD maintaining therapy SCFA
Online Access:	https://www.mdpi.com/2077-0383/9/12/3941

Similar Items

Inflammatory Bowel Disease Nurse—Practical Messages
by: Chiara Rosso, et al.
Published: (2021-04-01)

Calprotectin and SARS-CoV-2: A Brief-Report of the Current Literature
by: Mauro Giuffrè, et al.
Published: (2021-07-01)

Point of care testing of fecal calprotectin as a substitute for routine laboratory analysis
by: Julie Hejl, et al.
Published: (2018-03-01)

Evaluation of Different Extraction- and Analysis Methods for Calprotectin in Feces
by: Akgun, Kocere Kurdé
Published: (2012)

Utility of the combined use of 3 serologic markers in the diagnosis and monitoring of chronic enteropathies in dogs
by: Juan Estruch, et al.
Published: (2021-05-01)

Serum markers of Inflammatory Bowel Disease: A literature review
by: Siti Muchayat Purnamaningsih
Published: (2018-08-01)

Evaluation of ELISA and rapid test for the analysis of fecal Calprotectin
by: Albeer, Merna
Published: (2013)

Pomegranate juice to reduce fecal calprotectin levels in inflammatory bowel disease patients with a high risk of clinical relapse: Study protocol for a randomized controlled trial
by: Eleonora Scaioli, et al.
Published: (2019-06-01)

Laboratory Assessment of Disease Activity in Pediatric Patients with Inflammatory Bowel Disease: What’s New?
by: Rayna Shentova-Eneva, et al.
Published: (2020-12-01)

Correlation of Biomarkers with Endoscopic Score: Ulcerative Colitis Endoscopic Index of Severity (UCEIS) in Patients with Ulcerative Colitis in Remission
by: Corina Silvia Pop, et al.
Published: (2021-12-01)

Noninvasive biomarkers as surrogate predictors of clinical and endoscopic remission after infliximab induction in patients with refractory ulcerative colitis
by: Elham A Hassan, et al.
Published: (2017-01-01)

Faecal Inflammatory Biomarkers and Gastrointestinal Symptoms after Bariatric Surgery: A Longitudinal Study
by: Floris Westerink, et al.
Published: (2021-04-01)

IRON-FORTIFIED SYNBIOTIC FERMENTED MILK WITH TEMPEH EXTRACT TO ENHANCES PROPIONIC ACID, BUTYRIC ACID, AND NON-PATHOGEN MICROBIOME IN ANEMIC WISTAR RAT
by: Mohammad Juffrie, et al.
Published: (2020-06-01)

Utility of fecal calprotectin as a discriminative biomarker between ulcerative colitis and irritable bowel syndrome and its ability to be used for the assessment of the remission stage of ulcerative colitis
by: Hossam M Elsaadany, et al.
Published: (2016-01-01)

Quantification of Short Chain Fatty Acids (acetate, butyrate, propionate) in human blood with ion exclusion chromatography
by: Markus Bertges, et al.
Published: (2021-08-01)

Association of Infliximab and Vedolizumab Trough Levels with Reported Rates of Adverse Events: A Cross-Sectional Study
by: Ido Veisman, et al.
Published: (2021-09-01)

Dietary intervention with green dwarf banana flour (Musa sp. AAA) modulates oxidative stress and colonic SCFAs production in the TNBS model of intestinal inflammation
by: L.D. Almeida-Junior, et al.
Published: (2017-11-01)

Fecal calprotectin predicts complete mucosal healing and better correlates with the ulcerative colitis endoscopic index of severity than with the Mayo endoscopic subscore in patients with ulcerative colitis
by: Sun-Ho Lee, et al.
Published: (2017-10-01)

Butyrate Shapes Immune Cell Fate and Function in Allergic Asthma
by: William Yip, et al.
Published: (2021-02-01)

The Course of SARS-COV2 Infection Was Not Severe in a Crohn’s Patient Who Administered Maintenance Anti-TNF Therapy Overlapping the Early Pre-Symptomatic Period of Infection
by: Francis Okeke, et al.
Published: (2020-08-01)

CLINICAL SIGNIFICANCE OF CALPROTECTIN IN RHEUMATIC DISEASES
by: A. S. Avdeeva
Published: (2018-09-01)

The Association of Plasma-Free Branched-Chain Amino Acids with Disease Related Parameters in Ulcerative Colitis
by: Efstathia Papada, et al.
Published: (2020-10-01)

Targeting Immune Cell Trafficking – Insights From Research Models and Implications for Future IBD Therapy
by: Maximilian Wiendl, et al.
Published: (2021-05-01)

Does faecal calprotectin differentiate between inflammatory bowel disease colitis and non-inflammatory bowel disease colitides?
by: Ahmed F. Khalil, et al.
Published: (2020-11-01)

Bacteroides, butyric acid and t10,c12-CLA changes in colorectal adenomatous polyp patients
by: Ciyan Chen, et al.
Published: (2021-01-01)

Single Donor FMT Reverses Microbial/Immune Dysbiosis and Induces Clinical Remission in a Rat Model of Acute Colitis
by: Petra Adamkova, et al.
Published: (2021-02-01)

EP4 receptor-associated protein in macrophages ameliorates colitis and colitis-associated tumorigenesis
by: Nakatsuji, Masato
Published: (2016)

The level of faecal calprotectin as a noninvasive biomarker of mucosal healing in children with ulcerative colitis
by: Edyta Szymańska, et al.
Published: (2020-12-01)

Evaluation of the efficiency of dietary therapy for gastrointestinal food allergy in infants during the first year of life
by: T. A. Shumatova, et al.
Published: (2016-03-01)

Colitis in spondyloarthritis
by: Muhammed Hafis, et al.
Published: (2020-01-01)

General dentists' knowledge, attitude, and practice guidelines toward pediatric dentistry
by: Thabitha S Rani, et al.
Published: (2020-01-01)

Role of Fecal Calprotectin as a Noninvasive Indicator for Ulcerative Colitis Disease Activity
by: Nakov Radislav V., et al.
Published: (2019-06-01)

Immunomodulatory assessment of Portulaca oleracea L. extract in a mouse model of colitis
by: Manal A. Alfwuaires, et al.
Published: (2021-11-01)

Editorial: Inflammation and Fibrosis in the Gastrointestinal Tract and Liver: Mechanisms and Targets
by: Ralf Weiskirchen, et al.
Published: (2021-09-01)

Gut Microbiota and Iron: The Crucial Actors in Health and Disease
by: Bahtiyar Yilmaz, et al.
Published: (2018-10-01)

Fecal calprotectin: a marker for clinical differentiation of microscopic colitis and irritable bowel syndrome
by: von Arnim U, et al.
Published: (2016-04-01)

Fecal calprotectin concentration in neonatal necrotizing enterocolitis
by: Jung Min Yoon, et al.
Published: (2014-08-01)

Role of fecal calprotectin as a biomarker of intestinal inflammation in ulcerative colitis: a prospective study
by: Onişor Danusia, et al.
Published: (2018-07-01)

Dynamics of Colon Monocyte and Macrophage Activation During Colitis
by: Gareth-Rhys Jones, et al.
Published: (2018-11-01)

Ulcerative colitis: functional analysis of the in-depth proteome
by: Armin Schniers, et al.
Published: (2019-01-01)

Cannot write session to /tmp/vufind_sessions/sess_omvcs8pka6rfque0h6rpmpra1k